Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable knowledge share and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Cerlin Roberts on c.roberts@oxfordglobal.co.uk

Biomarkers & Precision Medicine USA Congress 2017 Speakers:

Eric Kowack, Vice President, Team Leadership and Head, Precision Medicine
Ignyta

Jaya Goyal, Vice President, Bioanalytical, Pharmacology and Biomarker Development
Wave Life Sciences

Brydon Bennett, Senior Director, Alliance Research – Inflammation and Immunology
Celgene

Martin Hodge, Senior Director, Systems Immunology and External Alliance Lead
Pfizer

Anka G. Ehrhardt, Director Clinical Cytometry, CTTO, ECTR
Bristol-Myers Squibb

Gary Li, Executive Director, Translational Oncology
Ignyta

Ernesto Munoz, Associate Director & Head of Biomarkers, Immunodermatology
Johnson & Johnson

Pavan Kumar, Director, Head of Biomarkers and Companion Diagnostics
H3 Biomedicine

Nan Bing, Director Human Genetics
Pfizer

Christopher Heery, Chief Medical Officer
Bavarian Nordic

Al Tsang, Chief Scientific Officer
Precision Biologics

James Christensen, Chief Scientific Officer
Mirati Therapeutics

John-Michael Sauer, Executive Director, Predictive Safety Testing Consortium
Critical Path Institute

Jean C. Zen Klusen, Director, The Cancer Genome Atlas, Center for Cancer Genomics, Office of the Director, National Cancer Institute
National Institutes of Health

David A. Fox, Professor of Internal Medicine
University of Michigan

and

Co-Chair of the Inflammation and Immunity Steering Committee
FNIH

Paul Rejto, Head of Oncology Translational Research
Pfizer

Stefan Kostense, Director Prevention Biomarker Assays
Janssen

Zhenhao Qi, Associate Director, Clinical Genetics and Genomics
Bristol Myers Squibb

Lisa Eli, Associate Director, Translational MEdicine & Diagnostics
Puma Biotechnology, Inc.

Saurabh Gupta, Associate Director, Translational Medicine Group
Takeda

Lukas Amler, Senior Director Oncology Biomarker Development
Genentech

Chris Twitty, Associate Director
OncoSec Medical

Vladimir Tolstikov, Director of Metabolomics
BERG Pharma

Nuzhat Pathan, Director, Translational Oncology
Pfizer

Colette Chevrier, Associate Director, Global Regulatory Medical Devices and Diagnostics
EMD Serono

Sarah Hersey, Head of Precision Medicine and Companion Diagnostics
Celgene

Hartmuth Kolb, Head of Neuroscience Biomarkers
Johnson & Johnson

Xuemei Zhao, Senior Principle Scientist
Merck

Jane Wang, Clinical Biomarker Lead, Medical Sciences, Translational Sciences
Amgen

Sarah Javaid, Associate Principal Scientist, Discovery Pharmacogenomics, Genetics & Pharmacogenomics
Merck

Marlon Rebelatto, Translational Pathologist
Medimmune

Chetan Deshpande, Senior Manager – Biomarker Assay Specialist Early Development, Translational and Immuno-Oncology (EDTO)
Pfizer

Amber Donahue, Biomarker Assay Specialist
Pfizer

Tracy Staton, Senior Scientist, Biomarker Development
Genentech